Keyphrases
Specific Peptide
100%
Cancer-specific
100%
Bladder Cancer
100%
124I
77%
Radiopharmaceuticals
22%
Non-invasive Diagnosis
22%
Tyrosine
11%
Tumor
11%
Tumor Targeting
11%
Melanoma
11%
High Selectivity
11%
Binding Affinity
11%
Cancer Imaging
11%
Human Bladder Cancer
11%
Biodistribution
11%
Common Cancers
11%
MicroPET
11%
Tumor Model
11%
Binding Selectivity
11%
Melanocytic Tumor
11%
B16F10 Melanoma
11%
18F-fluorodeoxyglucose (18F-FDG)
11%
Urinary Tract
11%
Disulfide Bond Formation
11%
Bladder Cancer Cells
11%
Cancer Xenograft Model
11%
Cystoscopy
11%
Tumor Uptake
11%
Radiochemical Yield
11%
Radioactive iodine-131
11%
Muscle Ratio
11%
Imaging Tracer
11%
Medicine and Dentistry
Bladder Cancer
100%
Iodine 124
63%
Neoplasm
27%
Malignant Neoplasm
18%
Non Invasive Measurement
18%
Radiopharmaceutical Agent
18%
Melanoma
18%
Disulfide
9%
Cancer Cell
9%
Binding Affinity
9%
Fluorodeoxyglucose F 18
9%
Tumor Xenograft
9%
Tumor Model
9%
Biodistribution
9%
Radioactive Tracer
9%
Cystoscopy
9%
Urinary Tract
9%
Iodine 131
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Iodine 124
63%
Neoplasm
27%
Malignant Neoplasm
18%
Melanoma
18%
Radiopharmaceutical Agent
18%
Disulfide Bond
9%
Biodistribution
9%
Tumor Model
9%
Tracer
9%
Iodine-131
9%
Fluorodeoxyglucose F 18
9%